P
Piero Barbanti
Researcher at Università telematica San Raffaele
Publications - 148
Citations - 3873
Piero Barbanti is an academic researcher from Università telematica San Raffaele. The author has contributed to research in topics: Migraine & Chronic Migraine. The author has an hindex of 29, co-authored 132 publications receiving 3065 citations. Previous affiliations of Piero Barbanti include Open University & Sapienza University of Rome.
Papers
More filters
Journal ArticleDOI
BI 44370 TA, an oral CGRP antagonist for the treatment of acute migraine attacks: Results from a phase II study
TL;DR: Efficacy of BI 44370 TA was shown in a dose-dependent manner in the treatment of acute migraine attacks, and the frequency of adverse events was low in all groups.
Journal ArticleDOI
Unilateral Cranial Autonomic Symptoms in Migraine
TL;DR: The presence of UAs suggests an activation of the trigeminal-autonomic reflex, probably related to an over-activation of thetrigeminal afferent arm, in patients with migraine patients.
Journal ArticleDOI
Noninvasive vagus nerve stimulation as acute therapy for migraine: The randomized PRESTO study
Cristina Tassorelli,Licia Grazzi,Marina de Tommaso,Giulia Pierangeli,Paolo Martelletti,Innocenzo Rainero,Stefanie Dorlas,Pierangelo Geppetti,Anna Ambrosini,Paola Sarchielli,Eric Liebler,Piero Barbanti +11 more
TL;DR: This randomized sham-controlled trial supports the abortive efficacy of nVNS as early as 30 minutes and up to 60 minutes after an attack and suggest effective pain relief, tolerability, and practicality of n VNS for the acute treatment of episodic migraine.
Journal ArticleDOI
A mechanism-based classification of pain in multiple sclerosis.
TL;DR: Nine types of MS-related pain are distinguished, which include trigeminal neuralgia and Lhermitte’s phenomenon, ongoing extremity pain, mixed pains secondary to lesions in the central motor pathways but mediated by muscle nociceptors, musculoskeletal pains, migraine, and treatment-induced pains.
Journal ArticleDOI
Donepezil in the treatment of hallucinations and delusions in Parkinson's disease.
Giovanni Fabbrini,Piero Barbanti,Cinzia Aurilia,Caterina Pauletti,Gian Luigi Lenzi,Giuseppe Meco +5 more
TL;DR: Donezepil was overall well tolerated, but a deterioration in motor disability was noted in 2 out of 8 patients, andHallucinations and delusions improved significantly in all patients.